2-chloro-N-{[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]methyl}acetamide
Structure Info
- Chemspace ID
- CSSB00160574730 (In-Stock Building Blocks)
- CAS
- 2411283-43-5
- IUPAC Name
- 2-chloro-N-{[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]methyl}acetamide
- Mol formula
- C11H9Cl2N3O2
- Mol weight
- 286 Da
- Catalog Number(s)
- AKOS041207314, BBLS00160574730, CSC160574730, CSCR01651004538, EN300-26589015, Z1562142010, bbls00160574730, s270062____7617902____8147258
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.14
- Heavy atoms count
- 18
- Rotatable bond count
- 4
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.181
- Polar surface area (Å)
- 68
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSSB00160574730
Items Overall 1 item from 1 supplier
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
![Chemical structure of 2-chloro-N-{[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]methyl}-2-fluoroacetamide - CSSB21332053632](/st/structure/200/f1d11a91f868724c645fc40f69b897ed/FC%2528Cl%2529C%2528%253DO%2529NCC1%253DNN%253DC%2528O1%2529C1%253DCC%253DC%2528Cl%2529C%253DC1.png)
![Chemical structure of 2-chloro-N-{[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]methyl}-N-cyclopropylacetamide - CSSB00000734638](/st/structure/200/1806f16fbfb2e02f868e1d59b4d0867a/ClCC%2528%253DO%2529N%2528CC1%253DNN%253DC%2528O1%2529C1%253DCC%253DC%2528Cl%2529C%253DC1%2529C1CC1.png)

![Chemical structure of 2-chloro-N-[2-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide - CSSB02005053081](/st/structure/200/a736e9cd296bb7227bce9055332d4fe2/O%253DC%2528CCl%2529NCCC1%253DNN%253DC%2528C2%253DCC%253DCC%253DC2%2529O1.png)
![Chemical structure of 3-[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]-N-methylpropanamide - CSSB02005053612](/st/structure/200/703e1df83f1b19913591c1fc02962379/CNC%2528%253DO%2529CCC1%253DNN%253DC%2528C2%253DCC%253DC%2528Cl%2529C%253DC2%2529O1.png)
![Chemical structure of 2-chloro-N-{[5-(4-chlorophenyl)-1,3,4-thiadiazol-2-yl]methyl}acetamide - CSSB21332080413](/st/structure/200/3086f784afb051757872575e44a65d35/ClCC%2528%253DO%2529NCC1%253DNN%253DC%2528S1%2529C1%253DCC%253DC%2528Cl%2529C%253DC1.png)
![Chemical structure of {[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]methyl}(methyl)amine - CSSB00000167990](/st/structure/200/2789bf7bf4d0b7c58d01941bd2416472/CNCC1%253DNN%253DC%2528O1%2529C1%253DCC%253DC%2528Cl%2529C%253DC1.png)
![Chemical structure of N-{[5-(3-bromophenyl)-1,3,4-oxadiazol-2-yl]methyl}-2-chloroacetamide - CSSB01565049387](/st/structure/200/4a13442b12a8ac2c70404a14c3ce412b/ClCC%2528%253DO%2529NCC1%253DNN%253DC%2528O1%2529C1%253DCC%253DCC%2528Br%2529%253DC1.png)
![Chemical structure of N-{[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]methyl}prop-2-enamide - CSSB00027710478](/st/structure/200/98a3a3b4d40f2cd2caac70b3cce7272a/ClC1%253DCC%253DC%2528C%253DC1%2529C1%253DNN%253DC%2528CNC%2528%253DO%2529C%253DC%2529O1.png)
